2021: The Milestone Year

OnMarket

Share via:

LinkedIn

Facebook

Email

OnMarket’s Capital Report - a must-read for 2022

OnMarket's 2021 Capital Report

2021 was another COVID19 impacted year; with toilet paper shortages, many online meetings, and low interest rates encouraging new investors to enter the Equity Markets. Throughout the chaos of it all, OnMarket is humbled and grateful to have reached another important milestone – raising $172m, from 66,000 investors, for 220 Australian businesses.

In light of this milestone, OnMarket created a behind-the-scenes video for those that made this achievement possible.

Click the image on the left to hear from the OnMarket team!

That’s not all! In the spirit of ‘new year new me’, OnMarket created an inaugural yearly resource – summarising all platform activities throughout 2021. The Capital Report analyses the investment opportunities provided to investors, their returns, hot sectors, and the capital raised for many incredible Australian businesses across a diverse range of sectors.

To download the 2021 Capital Report, please follow the link below.

Company Releases

OnMarket 2021 Capital Report 31 Dec 2021

Discover investment opportunities here.

Filter by Sort by

Wholesale Live

Baymatob Pty Ltd

AI platform for $5.7B fetal monitoring market, FDA Breakthrough Designation

Baymatob is a medtech company revolutionising maternal care with Oli™, an AI-driven tool for early detection of pregnancy and labor complications. Backed by Perennial, and Scale Investors, Oli targets the $5.7B fetal monitoring market and has FDA Breakthrough Designation (expedited review) to improve outcomes and reduce costly interventions.

$1.91Price

Up to $12 millionSize of Offer

22 Jul 25Offer Open

05 Aug 25Pay By

More Info

CSF Closed Jul 2025

PhycoLife (Venus Shell Systems P/L)

PhycoLife (Venus Shell Systems P/L) Equity Crowdfunding Offer has successfully closed. PhycoLife's core strength lies in their comprehensive mastery of the entire seaweed value chain. They're not simply product sellers; they are fundamental creators, meticulously managing every stage from proprietary indoor marine cultivation and advanced bio-refining to the formulation of market-leading health products.

Fully Funded

$1.85 million

Raised

790

Investors

See more past transactions

Wholesale Closed Jun 2025

Recludo Ltd

Recludo Ltd is consolidating the Australian mortgage broker industry by selectively investing in the top 5% of mortgage broker businesses. With over 22,000 independent mortgage brokers writing 75% of all new home loans, representing a $356 billion annual market opportunity, it is a highly fragmented market ripe for consolidation.